Furthermore, elevated levels of IL-2, IL-6, CRP, and anhedonia were related to poor treatment response in MDD (Craske et al., 2016; Zhang et al., 2019; Mosiołek et al., 2021). This evidence concerns the gene IL2 and major depressive disorder.